BioSpace News Archive

Policy

Noting Delta Variant, Pfizer/BioNTech Plan to Ask FDA for Booster Shot EUA

The two companies said a booster dose given six months after the second dose had a consistent tolerability profile while still creating high immune responses against the Alpha and Beta variant.

July 9, 2021
·
3 min read
·
Mark Terry
Job Trends

Chicago Biopharma Builds Commercial Facility in China to Focus on Antibody Development

Sparx Therapeutics is expanding its operations into Yangzhou, China, with the imminent construction of a 1.2 million square foot facility for its commercial production.

July 9, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Clinical Catch-Up: July 5-9

Last week presented a fair number of clinical trial news. Read on for more information.

July 9, 2021
·
6 min read
·
Mark Terry
$Valery Sharifulin\TASS via Getty Images$

Deals

Philip Morris Makes $1.44 Billion Bid for UK Inhaled Drug Specialist Vectura Group

Philip Morris will acquire Vectura to gain access to its inhaled drug formulas to bolster its Beyond Nicotine strategy.

July 9, 2021
·
2 min read
·
Alex Keown
Business

Inclusion and Diversity is Paramount to Sana’s Patient-Centric Culture

Sana Biotechnology, a gene and cell therapy hybrid whose mission is to create and deliver engineered cells as medicines for patients, puts the “I” first in Inclusion, Diversity and Equity (IDE).

July 9, 2021
·
5 min read
·
Heather McKenzie
Business

Muna Therapeutics Raises $73 Million to Advance Neurodegenerative Disease Focus

The company launches with the new funding to advance its focus on first-in-class small molecule therapies for neurodegenerative diseases.

July 9, 2021
·
2 min read
·
Brandon May
Pharmaceutical Continuous Manufacturing Market: Rising to be New Trend With its Magnificent Features

The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027.

July 9, 2021
·
4 min read
Deals

Sight Sciences Targets $160.5 Million IPO

It plans to trade under the SGHT ticker symbol.

July 9, 2021
·
2 min read
·
Mark Terry
Deals

Purdue Pharma Reorganization Gains Support from 15 States

The move by the 15 states’ attorneys general comes about a month ahead of a court hearing set for Aug. 5.

July 9, 2021
·
2 min read
·
Alex Keown
Drug Development

Ovid Realigns C-Suite After Throwing in the Towel on Phase III Candidate

This week’s announcement includes a step to the side for CMO Amit Rakhit, who will transition to the biotech’s advisory board.

July 9, 2021
·
2 min read
·
Kate Goodwin